Additional Information
Book Details
Abstract
This issue of Neurologic Clinics offers a rounded view of the latest therapeutic advances for the most common neurologic disorders and contains the following articles: Management Controversy in Chronic Daily Headaches (Rahmadan); Neurostimulation in Headache Patients (Dafer); The Selection of Anti-epileptic Drugs for the Treatment of Epilepsy in Children and Adults (Asconape); Management of Status Epilepticus in Adults (Rabinstein); Management of Blood Pressure in Acute and Hemorrhagic Stroke (Schneck); Modern Management of Brainstem Cavernous Malformations (Duckworth); Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas (Narayanan); Management of Motor Complications of Parkinson’s Disease (Espay); Therapeutic Challenges in Dystonias (Kartha); Management of Voltage Gated Potassium Channel Antibody Disorders (Merchut); Management of Critical Care Neuromyopathies (Chawla, Gruener); Approaches to Peripheral Nerve Disorders (Toussaint, Anderson); Management of Idiopathic Intracranial Hypertension (Digre, Spencer); Management of Low Grade Gliomas (Prabhu); Management of Acute, Recurrent, and Chronic Meningitdes in Adults (Venna); and Treatment Options for Adult Parasomnias (Attarian).
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Contributors | iii | ||
Contents | vii | ||
Preface | xv | ||
Chapter 1. Neurostimulation in Headache Disorders | 835 | ||
DEFINITION OF CHRONIC PRIMARY HEADACHE DISORDERS | 836 | ||
PATHOPHYSIOLOGY OF HEADACHE CHRONICITY | 836 | ||
MECHANISM OF NEUROSTIMULATION OF PRIMARY HEADACHE DISORDERS | 836 | ||
FEASIBILITY AND EFFICACY DATA | 837 | ||
SUMMARY | 838 | ||
REFERENCES | 838 | ||
Chapter 2. The Selection of Antiepileptic Drugs for the Treatment of Epilepsy in Children and Adults | 843 | ||
BASIC PRINCIPLES OF DRUG SELECTION | 844 | ||
SELECTION OF AED IN WOMEN | 849 | ||
EPILEPSY IN THE ELDERLY | 850 | ||
DRUG OF CHOICE FOR NEWLY DIAGNOSED EPILEPSY | 850 | ||
SUMMARY | 851 | ||
REFERENCES | 852 | ||
Chapter 3. Management of Status Epilepticus in Adults | 853 | ||
DEFINITION AND CLASSIFICATION | 853 | ||
MECHANISMS AND CAUSES | 854 | ||
DIAGNOSIS | 855 | ||
TREATMENT | 855 | ||
SUMMARY | 860 | ||
REFERENCES | 860 | ||
Chapter 4. Management of Arterial Blood Pressure in Acute Ischemic and Hemorrhagic Stroke | 863 | ||
EFFECT OF CHRONIC HYPERTENSION ON THE BRAIN | 864 | ||
PATHOPHYSIOLOGY OF ALTERATIONS IN ARTERIAL BLOOD PRESSURE IN ACUTE STROKE SYNDROMES | 864 | ||
SUBARACHNOID HEMORRHAGE AND CEREBRAL BLOOD FLOW | 865 | ||
INTRACEREBRAL HEMORRHAGE AND CEREBRAL BLOOD FLOW | 865 | ||
ISCHEMIC STROKE AND CEREBRAL BLOOD FLOW | 866 | ||
MANAGEMENT OF ARTERIAL BLOOD PRESSURE IN PRIMARY AND SECONDARY STROKE PREVENTION | 867 | ||
MANAGEMENT OF ARTERIAL BLOOD PRESSURE IN SUBARACHNOID HEMORRHAGE | 871 | ||
MANAGEMENT OF ARTERIAL BLOOD PRESSURE IN INTRACEREBRAL HEMORRHAGE | 872 | ||
MANAGEMENT OF ARTERIAL BLOOD PRESSURE IN ACUTE ISCHEMIC STROKE | 876 | ||
SUMMARY | 878 | ||
REFERENCES | 878 | ||
Chapter 5. Modern Management of Brainstem Cavernous Malformations | 887 | ||
NATURAL HISTORY | 888 | ||
MICROSURGERY | 888 | ||
RADIOSURGERY | 893 | ||
SUMMARY | 895 | ||
REFERENCES | 895 | ||
Chapter 6. Endovascular Management of Intracranial Dural Arteriovenous Fistulas | 899 | ||
PATHOPHYSIOLOGY | 899 | ||
CLASSIFICATION | 899 | ||
NATURAL HISTORY | 900 | ||
CLINICAL AND ANGIOGRAPHIC FEATURES | 902 | ||
TREATMENT | 904 | ||
COMBINED ENDOVASCULAR AND SURGICAL APPROACHES | 906 | ||
SUMMARY | 907 | ||
REFERENCES | 907 | ||
Chapter 7. Management of Motor Complications in Parkinson Disease: Current and Emerging Therapies | 913 | ||
CLINICAL FEATURES AND EPIDEMIOLOGY OF MOTOR COMPLICATIONS | 913 | ||
PATHOPHYSIOLOGY OF MOTOR COMPLICATIONS | 914 | ||
DYSKINESIAS | 915 | ||
MANAGEMENT OF DYSKINESIAS | 915 | ||
STRATEGIES FOR DYSKINESIAS UNDER INVESTIGATION | 918 | ||
MANAGEMENT OF ‘‘WEARING OFF’’ AND ‘‘OFF’’ STATE MOTOR SYMPTOMS | 918 | ||
FREEZING OF GAIT | 920 | ||
CONTINUOUS DOPAMINERGIC STIMULATION | 921 | ||
DEEP BRAIN STIMULATION | 922 | ||
EXPERIMENTAL SURGICAL APPROACHES | 922 | ||
SUMMARY | 922 | ||
ACKNOWLEDGMENTS | 923 | ||
REFERENCES | 923 | ||
Chapter 8. Therapeutic Challenges in Dystonia | 927 | ||
CLASSIFICATION | 927 | ||
THERAPY | 929 | ||
SUMMARY | 935 | ||
REFERENCES | 935 | ||
Chapter 9. Management of Voltage-Gated Potassium Channel Antibody Disorders | 941 | ||
NMT | 941 | ||
LE | 947 | ||
MORVAN SYNDROME (MVS) | 951 | ||
SUMMARY | 955 | ||
KEY POINT OUTLINE | 955 | ||
ACKNOWLEDGMENTS | 956 | ||
REFERENCES | 956 | ||
Chapter 10. Management of Critical Illness Polyneuropathy and Myopathy | 961 | ||
CRITICAL ILLNESS POLYNEUROPATHY: CAUSE | 963 | ||
CRITICAL ILLNESS POLYNEUROPATHY: CLINICAL MANIFESTATIONS | 963 | ||
CRITICAL ILLNESS POLYNEUROPATHY: ELECTRODIAGNOSTIC FEATURES | 964 | ||
CRITICAL ILLNESS POLYNEUROPATHY: PATHOLOGY AND PATHOPHYSIOLOGY | 964 | ||
CRITICAL ILLNESS MYOPATHY: CLINICAL MANIFESTATIONS | 964 | ||
CRITICAL ILLNESS MYOPATHY: ELECTRODIAGNOSTIC FEATURES | 966 | ||
CRITICAL ILLNESS MYOPATHY: PATHOLOGY AND PATHOPHYSIOLOGY | 966 | ||
COMBINED CRITICAL ILLNESS POLYNEUROPATHY AND MYOPATHY: CINM OR CINMA | 967 | ||
STEPWISE APPROACH TO THE MANAGEMENT OF SUSPECTED CRITICAL ILLNESS NEUROMUSCULAR ABNORMALITIES (CINMA) | 967 | ||
SUMMARY | 972 | ||
REFERENCES | 973 | ||
Chapter 11. What’s New in the Diagnosis and Treatment of Peripheral Nerve Entrapment Neuropathies | 979 | ||
THORACIC OUTLET SYNDROME | 980 | ||
MEDIAN NERVE ENTRAPMENT | 982 | ||
ULNAR NERVE ENTRAPMENT | 984 | ||
RADIAL NERVE ENTRAPMENT AT THE FOREARM | 986 | ||
SUPRASCAPULAR NERVE ENTRAPMENT | 987 | ||
ILIOINGUINAL, ILIOHYPOGASTRIC, AND GENITOFEMORAL NERVE ENTRAPMENT | 988 | ||
LATERAL FEMORAL CUTANEOUS NERVE ENTRAPMENT | 989 | ||
SAPHENOUS NERVE ENTRAPMENT | 989 | ||
OBTURATOR NERVE ENTRAPMENT | 990 | ||
SCIATIC NERVE ENTRAPMENT | 990 | ||
COMMON PERONEAL NERVE ENTRAPMENT AT THE KNEE | 991 | ||
POSTERIOR TIBIAL NERVE ENTRAPMENT AT THE ANKLE | 992 | ||
PUDENDAL NERVE ENTRAPMENT | 994 | ||
ENTRAPMENT NEUROPATHY AND DIABETES | 994 | ||
OCCIPITAL NEURALGIA | 995 | ||
NEUROSTIMULATION TECHNIQUES | 995 | ||
SUMMARY | 996 | ||
ACKNOWLEDGMENTS | 996 | ||
REFERENCES | 996 | ||
Chapter 12. Treatments for Neuro-Ophthalmologic Conditions | 1005 | ||
RETINAL VASCULAR OCCLUSION SYNDROMES | 1005 | ||
OPTIC NERVE DISORDERS | 1012 | ||
ACKNOWLEDGMENTS | 1029 | ||
REFERENCES | 1029 | ||
Chapter 13. Management of Diffuse Low-Grade Cerebral Gliomas | 1037 | ||
CLINICAL FEATURES | 1038 | ||
PATHOGENESIS | 1039 | ||
RADIOLOGICAL FINDINGS | 1040 | ||
NEUROPATHOLOGY | 1041 | ||
MANAGEMENT | 1043 | ||
PROGNOSIS AND OUTCOME | 1051 | ||
SUMMARY | 1052 | ||
REFERENCES | 1052 | ||
Chapter 14. Management of Acute, Recurrent, and Chronic Meningitides in Adults | 1061 | ||
ACUTE MENINGITIS | 1062 | ||
ACUTE BACTERIAL MENINGITIS | 1063 | ||
ACUTE VIRAL MENINGITIS | 1065 | ||
ACUTE MENINGITIS DUE TO OTHER CAUSES | 1068 | ||
RECURRENT MENINGITIS | 1080 | ||
Chapter 15. Treatment Options for Parasomnias | 1089 | ||
TREATMENT OF NREM PARASOMNIAS | 1091 | ||
TREATMENT OF REM PARASOMNIAS | 1093 | ||
TREATMENT OF OTHER PARASOMNIAS | 1095 | ||
FUTURE DIRECTIONS | 1099 | ||
SUMMARY | 1099 | ||
REFERENCES | 1099 | ||
Index | 1107 |